The efficacy of cetuximab plus PD-1 inhibitors as salvage therapy in PD-1 refractory patients with recurrent or metastatic head and neck squamous cell carcinoma. - Rongrong Hui; Xiulan Liu; Zongyu Fan; Honghai Ji; Dongliang Wei; Guoxin Ren (Journal of Cancer, 2024)